Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
![]()
Reuters NewMedia, Inc. - Saturday, December 21, 1996 13:34:00 PM
Ho, the scientific director of the Aaron Diamond AIDS Research Center which has been in the vanguard of the battle against AIDS in the medical community, pioneered the use of drug "cocktails" to combat HIV, providing the first glimmers of hope to people with AIDS for better and longer lives.
"When the history of this era is written, it is likely that the men and women who turned the tide on AIDS will be seen as true heroes of the age," Time said in a statement.
"For helping lift a death sentence... on tens of thousands of AIDS sufferers, and for pioneering the treatment that might, just might, lead to a cure, David Ho is TIME's Man of the Year for 1996," the magazine said.
"Some people make headlines while others make history," Time noted in its accompanying article.
The past year has seen the greatest advancement in the medical fight against AIDS since the epidemic began 15 years ago, largely through the development of protease inhibitors which when combined with other anti-HIV drugs often reduce the amount of virus in the blood to undetectable levels.
"My colleagues and I are greatly appreciative of this recognition," Ho said in a statement.
"While there is finally reason for optimism ... much work remains to be done. These advances represent an improvement in treatment, not a cure. We have seen HIV stagger, but this tough foe has not been knocked down," Ho, a virologist and professor at Rockefeller University, said.
Nearly 23 million people worldwide are estimated to be living with HIV or AIDS, according to a recent U.N. report. Since the epidemic began 6.4 million people, including 1.4 million children, have died, with 1.5 million succumbing to the disease in 1996.
Time has not selected its Man of the Year from the scientific community since 1960, when it named 15 U.S. scientists Men of the Year.
961221
RE961294
Copyright © 1996 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .